Graphical Abstract Instructions for Authors Create G raphical A bstract using template found in slide 2 of this deck or another program If using another program refer to Graphical Abstract Guidelines ID: 762659
Download Presentation The PPT/PDF document "Graphical Abstract Instructions for Auth..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Graphical Abstract Instructions for Authors Create G raphical A bstract using template found in slide 2 of this deck or another program. If using another program, refer to Graphical Abstract Guidelines for required specifications. Use exact title of accepted manuscript as the title of the Graphical Abstract. Place author’s last name and the year of publication at the bottom in the designated field. Place major conclusion or take-away point within the space provided in the “Conclusion” box. Refer to Graphical Library found in slides 3-6 for optional design elements and layout options. Additional sources for visual elements such as icons and pictorials can be found in slide 7. Refer to provided examples found in slides 8-12 for graphical layout ideas. D o not change the template without approval. U se Arial or Calibri fonts only with 18 pt size or larger. Size slide for widescreen (16:9 ratio ) with high-resolution (minimum of 300 dpi, preferably 600 dpi).
Paper Title Put conclusions here 1 st Author Last Name, Year Mutations11.8% (16) one78% (105)
Graphical Library
Text Text Text Text
Text Text Text Text Text Text
Graphic Sources Mindthegraph.com Canva.com Piktochart.com Easel.ly Infogram.com
Graphical Abstract Examples
Sporadic steroid-resistant n ephrotic syndrome (SRNS) in adults: Should we search for a genetic cause? Identified gene mutations associated with phenotypes with clinical implications of a molecular diagnosis for patients. Gribouval et al, 2018 135 patients -onset >18 years -not syndromic -FSGS and/or SRNS by biopsy -no family history of SRNS NGS targeted gene panel 35 SRNS genes Patient Selection Testing APOL1 10.4% (14) Mutations 11.8% (16) None 78% (105) SRNS Genes 56.3% (9) Type IV Collagen Genes 43.7% (7) Results
Development and validation of a renal risk score in ANCA-associated glomerulonephritis Renal Risk Score and mobile app were developed for predicting ESRD in ANCA-associated glomerulonephritis Brix et al , 2018 - 115 patients - Prospective - N ew diagnosis of ANCA-GN Training Cohort Renal Risk Score Validation Cohort - 90 patients - Identified risk factors for ESRD Mobile Application - “ANCA Renal Risk Score” application for mobile devices